Jacobs Levy Equity Management’s Labcorp LH Stock Holding History

Jacobs Levy Equity Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,579	Closed	-$606K	–	1107
2020 Q1	$606K	Sell	5,579 -2,269	-29%	-$327K	0.01%	720
2019 Q4	$1.14M	Sell	7,848 -10,520	-57%	-$1.52M	0.01%	670
2019 Q3	$2.65M	Buy	18,368 +9,824	+115%	+$1.43M	0.03%	456
2019 Q2	$1.27M	Buy	+8,544	New	+$1.19M	0.02%	603
2016 Q1	–	Sell	-17,467	Closed	-$1.85M	–	1151
2015 Q4	$1.85M	Sell	17,467 -1,304	-7%	-$135K	0.04%	364
2015 Q3	$1.75M	Hold	18,771	–	–	0.04%	387
2015 Q2	$1.96M	Sell	18,771 -35,432	-65%	-$3.69M	0.04%	381
2015 Q1	$5.87M	Buy	54,203 +34,450	+174%	+$3.54M	0.1%	211
2014 Q4	$1.83M	Buy	+19,753	New	+$1.74M	0.03%	400

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jacobs Levy Equity Management's LH Position: Q2 2020 in Review

Jacobs Levy Equity Management sold out of Labcorp (LH) in Q2 2020, closing a stake of 5,579 shares — an estimated $606K sold.

Jacobs Levy Equity Management first reported a position in LH in Q4 2014 and held it in 9 quarters. The position peaked at $5.87M in Q1 2015. 798 funds tracked by Wall St. Rank hold LH as of Q2 2020.

Jacobs Levy Equity Management reported no remaining Labcorp position as of Q2 2020 after selling out during the quarter.
Jacobs Levy Equity Management sold 5,579 Labcorp shares in Q2 2020, an estimated $606K.
Jacobs Levy Equity Management first reported a position in Labcorp in Q4 2014 and held it in 9 quarters.
Jacobs Levy Equity Management's Labcorp position peaked at $5.87M in Q1 2015.
798 funds tracked by Wall St. Rank held Labcorp as of Q2 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2020, filed 17 Aug 2020.